Feline
Stem Cells

Feline Chronic Gingivostomatitis – Current Concepts in Clinical Management

Master the latest in FCGS diagnosis, immune pathogenesis, and evolving treatment protocols.

1 CE Credit
Maria Soltero-Rivera
Maria Soltero-Rivera
DVM, DACVD

About the Course

Feline Chronic Gingivostomatitis (FCGS) is a debilitating, chronic inflammatory oral mucosal disease that affects 0.7%-26% of domestic cats. For over 3 decades, the etiology of feline chronic gingivostomatitis (FCGS) has been considered elusive and challenging. The current etiologic theories for FCGS include: an immune response to chronic antigenic stimulation, chronic viral infection(s), and a potential genetic predisposition. Without knowledge of the etiology of FCGS, as clinicians, we have focused on symptomatic and/or aggressive treatment options that may not lead to a cure. No single treatment has achieved a clinical success rate close to 100%, and cats that fail to respond to treatment require lifelong medical management or euthanasia. This lecture will review historical knowledge of FCGS, as well as discuss the most recent updates related to the etiopathogenesis and treatment of this disease.

This program has been RACE approved (20-1297943) for 1 hour of continuing education credit for veterinarians and veterinary technicians/technologists in jurisdictions that recognize RACE approval.

Learning objectives

  • Understand the clinical manifestations of Feline Chronic Gingivostomatitis (FCGS)
  • Differentiate FCGS from other oral diseases in cats
  • Understand the immune-mediated nature of FCGS
  • Identify other factors impacting the etiology of FCGS
  • Gain insight into upcoming innovative therapies and how they target FCGS

Start Learning Now

Explore courses, grow your skills, and earn CE credits - all at your pace.

4.7 Score

What our learners say about growing their skills and reaching new goals.

This was a great presentation from Boaz Arzi- informative, organized and well-spoken.
Thank you so much.
Colleen O'Morrow

Colleen O'Morrow
Veterinarian at Northern Lights Animal Dental Services

Very detailed though the research was a limited pool, would have liked to see more studies referenced.

Cassidy Abrahamson
Veterinary Technician at Platt College - Los Angeles

Great information. Thank you! I will be sharing this information with the doctors I work with.

Graciela Yaeger
Veterinary Technician at Animal Hospital of Lake Villa

About the presenter

Maria Soltero-Rivera

Maria Soltero-Rivera

DVM, DACVD

Dr. Maria Soltero-Rivera is a tenure-track Assistant Professor of Dentistry and Oral Surgery at the Department of Surgical and Radiological Sciences, UC Davis School of Veterinary Medicine. Dr. Soltero-Rivera completed her residency-training program in dentistry and oral surgery at PennVet and has worked as a visiting scientist at Dr. Joe De Risi’s lab, focusing on illuminating feline gingivostomatitis causative agents using metatranscriptomic next-generation RNA sequencing technology.

Dr. Maria Soltero-Rivera is a Diplomate of the American Veterinary Dental College (AVDC). Dr. Soltero-Rivera’s clinical and research focus is on oral medicine. Her lab investigates the diagnosis and treatment of chronic oral inflammatory disease in dogs and cats by analyzing the oral microbiome, the interkingdom interactions within this, and the host response with the goal of translational implications.

Continue Learning

See all

Stem Cell Therapy in Veterinary Practice: Sources, Administration, and Mechanisms of Action

Learn the basics of stem cell biology, sourcing, therapeutic delivery, and immune-modulating effects.

Speakers: Rebecca Windsor, DVM, DACVIM (Neurology)
Duration: 1h10m

Feline Chronic Gingivostomatitis and Mesenchymal Stem Cells

Explore the science, clinical outcomes, and practical use of stem cell therapy for FCGS.

Speakers: Boaz Arzi, DVM, DAVDC, DEVDC, FF-AVDC-OMFS
Duration: 1h 20m

Uterine-Derived Stem Cells for the Management of Refractory Feline Chronic Gingivostomatitis

Explore current treatment approaches for FCGS and examine clinical trial outcomes using uterine-derived stem cell therapy.

Speakers: MJ Redman, DVM, DAVDC
Duration: 1h